Mr. Graham Farrell reports
CIPHER PHARMACEUTICALS SCHEDULES Q4 & FISCAL 2025 EARNINGS RELEASE AND CONFERENCE CALL
Cipher Pharmaceuticals Inc. will release its financial results for the fourth quarter and fiscal 2025 after the market close on Thursday, March 12, 2026. The company will also hold a conference call on Friday, March 13, 2026, at 8:30 a.m. ET to discuss the results and corporate developments.
Conference call details
Date: Friday, March 13, 2026
Time: 8:30 a.m. ET
Dial-in number: 416-945-7677 or 888-699-1199
Replay: v
Expires:
March 20, 2026
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.
© 2026 Canjex Publishing Ltd. All rights reserved.